Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Essen Biotech
Royal Marsden NHS Foundation Trust
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
University of Southern California
Memorial Sloan Kettering Cancer Center
Institut Bergonié
Maria Sklodowska-Curie National Research Institute of Oncology
Gustave Roussy, Cancer Campus, Grand Paris
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
University of California, Irvine
Dana-Farber Cancer Institute
Yonsei University
University of Iowa
Memorial Sloan Kettering Cancer Center
Sarcoma Oncology Research Center, LLC
Fred Hutchinson Cancer Center
University of Miami
UNICANCER
Wake Forest University Health Sciences
Herlev and Gentofte Hospital
Fred Hutchinson Cancer Center
Sarcoma Alliance for Research through Collaboration
Western Regional Medical Center